Speaker Profile

Head, US Precision Medicine, Blueprint Medicines

Biography
Keith brings nearly 20 years of experience in developing and commercializing oncology diagnostics, including companion diagnostics (CDx). Prior to his role at Blueprint Medicines, he served as the commercial lead for LabCorp’s Oncology division, Integrated Oncology. During this time, he led a range of focus areas spanning the drug and diagnostic development continuum. Prior to this, he served in a variety of roles including diagnostics sales and marketing (both on the diagnostics and oncology therapeutics side) and obtained his MBA at NYU, Stern School of Business.


Talk
Winning FDA Approval for GIST Precision Therapy
Precision medicine continues to make rapid advances in oncology – with multiple therapies falling under breakthrough therapy designation, real-time review and pan-cancer indications. This talk will focus on the opportunities and challenges faced by biopharmaceutical companies and precision medicine stakeholders through the lens of Blueprint Medicines clinical portfolio.


×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by MAR. 28TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required